Skip to content

Clinical trials

Completed Phase 3 Hemoglobinuria, Paroxysmal trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemoglobinuria, Paroxysmal Phase: Phase 3 Status: Completed Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20043
20052
20161
20172
20184
20195
20202
20212
20232
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alexion Pharmaceuticals, Inc.10
Novartis Pharmaceuticals3
AO GENERIUM2
Apellis Pharmaceuticals, Inc.2
Biocad2
Chengdu Suncadia Medicine Co., Ltd.2
National Heart, Lung, and Blood Institute (NHLBI)2
St. Jude Children's Research Hospital2
AKARI Therapeutics1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemoglobinuria, Paroxysmal29
Anemia3
Hemolysis3
Hemoglobinuria2
Leukemia, Myeloid, Acute2
Leukemia, Myelomonocytic, Juvenile2
Lymphoma, Non-Hodgkin2
Myelodysplastic Syndromes2
Anemia, Hemolytic1
Bone Marrow Diseases1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.